Monday, July 9, 2007

Roche backs RNAi research with $1 bln Alnylam deal (Reuters)



Reuters - Roche Holding AG has
signed a deal worth up to $1 billion with Alnylam
Pharmaceuticals Inc. , giving it access to the U.S.
firm's skills in the new science of RNA interference.

Source: http://rss.news.yahoo.com

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)